<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(6)</volume><submitter>Su CW</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Whether or not hepatitis B virus (HBV) genotypes, mutations, and viral loads determine outcomes for patients with HBV-induced hepatocellular carcinoma (HCC) remains controversial.&lt;h4>Aims&lt;/h4>To study the influence of HBV viral factors on prognoses for patients with HBV-induced HCC after resection surgery and investigate if antiviral therapy could counteract the adverse effects of viral factors.&lt;h4>Methods&lt;/h4>A total of 333 HBV-related HCC patients who underwent tumor resection were enrolled retrospectively. Serum HBV DNA levels, mutations, anti-viral therapy, and other clinical variables were analyzed for their association with post-operative recurrence.&lt;h4>Results&lt;/h4>After a median follow-up of 45.9 months, 208 patients had HCC recurrence after resection. The 5-year </pubmed_abstract><journal>PloS one</journal><pagination>e66457</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3689837</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.</pubmed_title><pmcid>PMC3689837</pmcid><pubmed_authors>Chiou YW</pubmed_authors><pubmed_authors>Huo TI</pubmed_authors><pubmed_authors>Wu JC</pubmed_authors><pubmed_authors>Su CW</pubmed_authors><pubmed_authors>Tsai YH</pubmed_authors><pubmed_authors>Teng RD</pubmed_authors><pubmed_authors>Lei HJ</pubmed_authors><pubmed_authors>Chau GY</pubmed_authors><pubmed_authors>Hung HH</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.</name><description>&lt;h4>Background&lt;/h4>Whether or not hepatitis B virus (HBV) genotypes, mutations, and viral loads determine outcomes for patients with HBV-induced hepatocellular carcinoma (HCC) remains controversial.&lt;h4>Aims&lt;/h4>To study the influence of HBV viral factors on prognoses for patients with HBV-induced HCC after resection surgery and investigate if antiviral therapy could counteract the adverse effects of viral factors.&lt;h4>Methods&lt;/h4>A total of 333 HBV-related HCC patients who underwent tumor resection were enrolled retrospectively. Serum HBV DNA levels, mutations, anti-viral therapy, and other clinical variables were analyzed for their association with post-operative recurrence.&lt;h4>Results&lt;/h4>After a median follow-up of 45.9 months, 208 patients had HCC recurrence after resection. The 5-year </description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2026-05-04T14:21:35.708Z</modification><creation>2026-04-07T20:34:50.949Z</creation></dates><accession>S-EPMC3689837</accession><cross_references><pubmed>23805222</pubmed><doi>10.1371/journal.pone.0066457</doi></cross_references></HashMap>